These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Interaction of human IgE with soluble forms of IgE high affinity receptors. Liu J; Ruppel J; Shire SJ Pharm Res; 1997 Oct; 14(10):1388-93. PubMed ID: 9358551 [TBL] [Abstract][Full Text] [Related]
5. Use of an anti-IgE humanized monoclonal antibody in ragweed-induced allergic rhinitis. Casale TB; Bernstein IL; Busse WW; LaForce CF; Tinkelman DG; Stoltz RR; Dockhorn RJ; Reimann J; Su JQ; Fick RB; Adelman DC J Allergy Clin Immunol; 1997 Jul; 100(1):110-21. PubMed ID: 9257795 [TBL] [Abstract][Full Text] [Related]
6. Treatment of allergic asthma with monoclonal anti-IgE antibody. rhuMAb-E25 Study Group. Milgrom H; Fick RB; Su JQ; Reimann JD; Bush RK; Watrous ML; Metzger WJ N Engl J Med; 1999 Dec; 341(26):1966-73. PubMed ID: 10607813 [TBL] [Abstract][Full Text] [Related]
7. [Treatment of allergic diseases with monoclonal anti-IgE antibody]. Morita Y Nihon Rinsho; 2001 Oct; 59(10):2019-22. PubMed ID: 11676148 [TBL] [Abstract][Full Text] [Related]
8. [Monoclonal antibody therapy for allergic asthma]. Nishikawa M; Matsuse T Nihon Rinsho; 2002 Mar; 60(3):591-7. PubMed ID: 11904978 [TBL] [Abstract][Full Text] [Related]
9. Effect of anti-IgE antibodies on Fc epsilonRI-bound IgE. Rudolf MP; Furukawa K; Miescher S; Vogel M; Kricek F; Stadler BM J Immunol; 1996 Dec; 157(12):5646-52. PubMed ID: 8955217 [TBL] [Abstract][Full Text] [Related]
10. An anti-IgE monoclonal antibody that binds to IgE on CD23 but not on high-affinity IgE.Fc receptors. Shiung YY; Chiang CY; Chen JB; Wu PC; Hung AF; Lu DC; Pan RL; Chang TW Immunobiology; 2012 Jul; 217(7):676-83. PubMed ID: 22226669 [TBL] [Abstract][Full Text] [Related]
11. Engineering the Fab fragment of the anti-IgE omalizumab to prevent Fab crystallization and permit IgE-Fc complex crystallization. Mitropoulou AN; Ceska T; Heads JT; Beavil AJ; Henry AJ; McDonnell JM; Sutton BJ; Davies AM Acta Crystallogr F Struct Biol Commun; 2020 Mar; 76(Pt 3):116-129. PubMed ID: 32133997 [TBL] [Abstract][Full Text] [Related]
12. Anti-IgE as novel therapy for the treatment of asthma. Fick RB Curr Opin Pulm Med; 1999 Jan; 5(1):76-80. PubMed ID: 10813254 [TBL] [Abstract][Full Text] [Related]
13. Molecular basis for nonanaphylactogenicity of a monoclonal anti-IgE antibody. Rudolf MP; Zuercher AW; Nechansky A; Ruf C; Vogel M; Miescher SM; Stadler BM; Kricek F J Immunol; 2000 Jul; 165(2):813-9. PubMed ID: 10878355 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of allergic reactions with antibodies to IgE. Shields RL; Whether WR; Zioncheck K; O'Connell L; Fendly B; Presta LG; Thomas D; Saban R; Jardieu P Int Arch Allergy Immunol; 1995; 107(1-3):308-12. PubMed ID: 7613156 [TBL] [Abstract][Full Text] [Related]
15. Structure of the omalizumab Fab. Jensen RK; Plum M; Tjerrild L; Jakob T; Spillner E; Andersen GR Acta Crystallogr F Struct Biol Commun; 2015 Apr; 71(Pt 4):419-26. PubMed ID: 25849503 [TBL] [Abstract][Full Text] [Related]
16. Epitope-specific antibody response to IgE by mimotope immunization. Rudolf MP; Vogel M; Kricek F; Ruf C; Zürcher AW; Reuschel R; Auer M; Miescher S; Stadler BM J Immunol; 1998 Apr; 160(7):3315-21. PubMed ID: 9531289 [TBL] [Abstract][Full Text] [Related]
17. Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab). Milgrom H; Berger W; Nayak A; Gupta N; Pollard S; McAlary M; Taylor AF; Rohane P Pediatrics; 2001 Aug; 108(2):E36. PubMed ID: 11483846 [TBL] [Abstract][Full Text] [Related]
18. Structural basis for selective inhibition of immunoglobulin E-receptor interactions by an anti-IgE antibody. Chen JB; Ramadani F; Pang MOY; Beavil RL; Holdom MD; Mitropoulou AN; Beavil AJ; Gould HJ; Chang TW; Sutton BJ; McDonnell JM; Davies AM Sci Rep; 2018 Aug; 8(1):11548. PubMed ID: 30069035 [TBL] [Abstract][Full Text] [Related]